Neurovascular Catheters Market Size to Worth Around USD 14.83 Bn by 2030

The global Neurovascular Catheters market size is expected to reach USD 14.83 billion by 2030 and is expected to expand at a CAGR of 10.7% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38465

Growth Factors

Increasing demand for minimally invasive neurosurgical procedures, rising prevalence of stroke and brain aneurysm, and technological advancements are driving the market.

Stroke is the most common cause of death, followed by heart and cancer diseases worldwide. For instance, according to WHO, in 2016, 15.2 million deaths of the 56.9 million deaths worldwide were due to stroke. Acute Ischemic Stroke (AIS) is the most common form of stroke caused due to reduced blood supply to the brain, making brain cells die. For instance, according to the U.S. CDC, 87.0% of strokes are classified as ischemic strokes, with the U.S. being the most commonly affected country. 

Report Highlights

 the embolization catheters segment dominated the market with a revenue share of over 35%. The segment is expected to expand at the highest revenue-based CAGR of 10.6% during the forecast period. Based on type, the market for neurovascular catheters is segmented into microcatheters, balloon catheters, access catheters, embolization catheters, and others.

the brain aneurysm segment dominated the market with a revenue share of more than 40.0% owing to factors such as the increasing incidence of brain aneurysms, new product launches by various market players, and increasing awareness among the population about the treatment of brain aneurysm. Neurovascular catheters are used in the treatment of various diseases and conditions, such as embolic stroke, brain aneurysm, arteriovenous malformations, and other disorders.

The others segment is expected to register the highest revenue-based CAGR of 17.2% during the forecast period. The increasing number of patients suffering from atherosclerosis and intracranial artery stenosis, government initiatives, and an increase in the R&D investment are a few factors contributing to the segment growth.

The hospitals segment dominated the market in 2020 and held a revenue share of more than 60.0%. Government funding, the availability of advanced products, and the presence of skilled neurosurgeons are a few factors driving the segment. In addition, the rising number of hospitals worldwide and improving healthcare infrastructure in developing countries are driving the segment. The ambulatory surgical centers segment is expected to expand at the highest revenue-based CAGR of 10.8% during the forecast period.

North America dominated the market and accounted for a revenue share of more than 40.0% in 2020. This can be attributed to the increasing incidence of neurological diseases, supportive government policies, favorable reimbursement policies, and growing awareness.

Key Players

  • Medtronic
  • Stryker
  •  phenox GmbH
  •  Penumbra, Inc.
  •  Integer Holdings Corporation
  •  Terumo Corporation
  •  Integra LifeSciences Corporation
  •  Biomerics
  •  Acandis GmbH
  • Spiegelberg GmbH & Co. KG.
Report Coverage Details
Market Size US$ 14.83 billion by 2030
Growth Rate CAGR of 10.7% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Type, Application, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Medtronic; Stryker; phenox GmbH; Penumbra, Inc.; Integer Holdings Corporation; Terumo Corporation; Integra LifeSciences Corporation; Biomerics; Acandis GmbH; Spiegelberg GmbH & Co. KG

Market Segmentation

  • Type
    • Microcatheters
    • Balloon Catheters
    • Access Catheters
    • Embolization Catheters
    • Others
  • Application
    • Embolic Stroke
    • Brain Aneurysm
    • Arteriovenous Malformations
    • Others
  • End-use
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38465

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Neurovascular Catheters Market, By Type

7.1.  Neurovascular Catheters Market, by Type, 2021-2030

7.1.1.    Microcatheters

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Balloon Catheters

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Access Catheters

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Embolization Catheters

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Others

7.1.5.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Neurovascular Catheters Market, By Application

8.1.  Neurovascular Catheters Market, by Application, 2021-2030

8.1.1.    Embolic Stroke

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Brain Aneurysm

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Arteriovenous Malformations

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Others

8.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Neurovascular Catheters Market, By End-use

9.1.  Neurovascular Catheters Market, by End-use, 2021-2030

9.1.1.    Hospitals

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Clinics

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Ambulatory Surgical Centers

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Diagnostic Centers

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Neurovascular Catheters Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Type (2017-2030)

10.1.2.  Market Revenue and Forecast, by Application (2017-2030)

10.1.3.  Market Revenue and Forecast, by End-use (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Type (2017-2030)

10.2.2.  Market Revenue and Forecast, by Application (2017-2030)

10.2.3.  Market Revenue and Forecast, by End-use (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Type (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Type (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Type (2017-2030)

10.3.2.  Market Revenue and Forecast, by Application (2017-2030)

10.3.3.  Market Revenue and Forecast, by End-use (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Type (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Type (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Type (2017-2030)

10.4.2.  Market Revenue and Forecast, by Application (2017-2030)

10.4.3.  Market Revenue and Forecast, by End-use (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Type (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Type (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Type (2017-2030)

10.5.2.  Market Revenue and Forecast, by Application (2017-2030)

10.5.3.  Market Revenue and Forecast, by End-use (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Type (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Type (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 11.  Company Profiles

11.1.              Medtronic

11.1.1.  Company Overview

11.1.2.  Type Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Stryker

11.2.1.  Company Overview

11.2.2.  Type Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              phenox GmbH

11.3.1.  Company Overview

11.3.2.  Type Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Penumbra, Inc.

11.4.1.  Company Overview

11.4.2.  Type Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Integer Holdings Corporation

11.5.1.  Company Overview

11.5.2.  Type Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Integer Holdings Corporation

11.6.1.  Company Overview

11.6.2.  Type Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Integra LifeSciences Corporation

11.7.1.  Company Overview

11.7.2.  Type Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Biomerics

11.8.1.  Company Overview

11.8.2.  Type Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Acandis GmbH

11.9.1.  Company Overview

11.9.2.  Type Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Spiegelberg GmbH & Co. KG.

11.10.1.               Company Overview

11.10.2.               Type Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38465

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com